Hypothesis

Age‑related accumulation of senescent intestinal epithelial cells (IECs) actively suppresses the apical sodium‑dependent bile acid transporter (ASBT) through SASP‑mediated interference with glucocorticoid receptor (GR) signaling. This repression lowers bile acid reabsorption, elevates luminal bile acids, and activates TGR5‑dependent signaling that restrains intestinal epithelial stem cell (IESC) proliferation. Senolytic clearance of senescent IECs would therefore restore ASBT, decrease luminal bile acids, blunt TGR5 signaling, and unleash IESC hyperproliferation—a trade‑off where removing the "hostage negotiator" removes a protective brake on tissue growth.

Mechanistic Model

• Senescent IECs secrete IL‑6, TNFα, and IL‑1β (core SASP).
• These cytokines activate STAT3 and NF‑κB pathways in neighboring IECs, leading to upregulation of SIRT1 and increased expression of miR‑21.
• SIRT1 deacetylates GR, reducing its ligand‑dependent transcriptional activity; miR‑21 directly targets GR mRNA for degradation.
• Impaired GR signaling diminishes transcription of the ASBT gene (SLC10A2) despite normal receptor levels.
• Reduced ASBT activity lowers ileal bile acid uptake, increasing luminal concentrations of secondary bile acids (e.g., deoxycholic acid).
• Elevated luminal bile acids activate TGR5 on enteroendocrine cells, stimulating GLP‑1 and PYY release, which act paracrinely to inhibit IESC proliferation via cAMP‑PKA signaling.
• Thus, senescence creates a feedback loop: SASP → GR inhibition → ↓ASBT → ↑luminal bile acids → ↑TGR5 signaling → ↓IESC proliferation.

Hypothesis

We propose that the microbiome metabolite indole‑3‑propionic acid (IPA) maintains intestinal stem cell (ISC) fitness not merely by reinforcing the epithelial barrier but by directly activating PXR‑dependent transcriptional programs that upgrade proteasome activity, boost homologous recombination repair, and preserve telomere length. When IPA‑PXR signaling wanes with age‑related dysbiosis, ISCs accumulate proteotoxic stress, DNA damage, and telomere attrition before measurable barrier loss, driving a precancerous, senescent stem cell pool.

Mechanistic Rationale

1. Proteostasis boost – PXR heterodimerizes with RXR to induce expression of the immunoproteasome subunits PSMB8 and PSMB9, as shown in liver xenograft models (see [2]). In ISCs, this shift accelerates degradation of oxidized proteins and misfolded transcription factors, reducing p62‑positive aggregates.
2. DNA repair coupling – PXR activation upregulates BRCA1 and RAD51 via a conserved DR4 response element in their promoters (in silico analysis of mouse and human genomes). Elevated BRCA1/RAD51 enhances homologous recombination, lowering γH2AX foci after oxidative challenge.
3. Telomere maintenance – PXR drives transcription of TERT through a downstream enhancer bound by FOXO3, a known PXR target. Increased TERT activity stabilizes telomere length in rapidly cycling ISCs, counteracting the telomere shortening observed in aged gut epithelium.
4. Developmental switch – The perinatal rise in PXR expression (see [4]) coincides with a surge in colonic IPA production from Clostridium sporog

Hypothesis

The aged bone marrow niche does not merely permit passive decline of hematopoietic stem cells (HSCs); it actively measures HSC metabolic fitness and eliminates those falling below a threshold, akin to synaptic pruning of inefficient neurons. This niche‑driven metabolic pruning is mediated by stromal CCL5 and endothelial NF‑κB signaling that senses low mitochondrial oxidative phosphorylation (OXPHOS) and elevated ROS in HSCs, triggering their removal or myeloid skewing. Consequently, erythropoiesis suffers as a side‑effect of losing OXPHOS‑competent, lymphoid‑biased HSCs, while myeloid‑biased, glycolytic HSCs persist because they are tolerated by the inflammatory niche. Enhancing HSC mitochondrial fitness should therefore resist niche‑eviction, restore balanced output, and improve erythropoiesis without the bone‑loss side effects of high‑dose EPO.

Novel Mechanistic Insight

1. Metabolic checkpoint in the niche – Aged mesenchymal stromal cells upregulate CCL5 in response to HIF‑1α stabilization caused by niche hypoxia and adipocyte accumulation. CCL5 acts as a “danger” signal that binds CCR5 on HSCs with low OXPHOS, activating NF‑κB in both stroma and hematopoietic cells.
2. ROS‑dependent feedback – HSCs with compromised mitochondria produce excess ROS, which oxidizes cysteine residues on the CCL5‑CCR5 complex, prolonging signaling and reinforcing NF‑κB activation. This creates a feed‑forward loop that selectively amplifies pruning of metabolically weak HSCs.
3. Parallel to neuronal pruning – Just as microglia complement tagging marks weakly act

Hypothesis

Acarbose extends lifespan more strongly in male mice because estrogen‑dependent downregulation of the colonic short‑chain fatty acid (SCFA) receptor FFAR2 (GPR43) in females limits SCFA‑driven AMPK activation in the gut‑brain axis, reducing systemic metabolic benefits.

Rationale

• Acarbose increases luminal SCFAs, especially butyrate, which activate AMPK via FFAR2/FFAR3 on enteroendocrine cells and vagal afferents (1).
• AMPK activation improves hepatic insulin sensitivity, reduces inflammation, and promotes autophagy—processes linked to longevity.
• Estradiol suppresses FFAR2 transcription in intestinal epithelium through estrogen receptor‑α (ERα) binding to an upstream enhancer element, a mechanism demonstrated in human colon carcinoma cells (4).
• Consequently, female mice experience a blunted SCFA‑FFAR2 signal despite comparable microbiome shifts, leading to weaker AMPK activation and smaller lifespan gains.

Testable Predictions

1. Receptor Expression: Colonic FFAR2 mRNA and protein levels will be significantly lower in female versus male mice fed acarbose, and this difference will be abolished by ovariectomy or ERα antagonism.
2. Pharmacological Rescue: Treating female acarbose‑treated mice with a selective FFAR2 agonist (e.g., MK‑8666) will restore AMPK phosphorylation in the liver and hypothalamus to male‑like levels and increase median lifespan by ≥15%.
3. Neural Activation: Females will show reduced c‑Fos activation in the nucl

Hypothesis

It's hypothesized that restoring ATF4 expression specifically in senescent cells will re‑activate the ISR negative feedback loop, thereby lowering chronic JNK‑AP‑1 activity and dampening the SASP while preserving acute stress‑induced JNK signaling.

Mechanistic Rationale

Senescent cells show persistent eIF2α phosphorylation but fail to translate ATF4 due to defective ribosome recruitment [1]. It's this block that prevents GADD34 synthesis, keeping eIF2α phosphorylated and disabling the feedback that normally dampens JNK. Chronic JNK then drives mitochondrial ROS, cytoplasmic chromatin formation and SASP amplification [2]. Histone variant H2A.J further locks inflammatory genes in an active chromatin state [4]. If ATF4 is re‑expressed, GADD34 will restore eIF2α dephosphorylation, reducing global translation attenuation and allowing renewed synthesis of stress‑adaptive proteins. Additionally, ATF4 can induce REDD1; it's known to inhibit mTORC1 and lower mitochondrial ROS production, breaking the ROS‑JNK feed‑forward loop. Moreover, ATF4‑dependent transcription of specific miRNAs (e.g., miR‑211) can target JNK scaffold proteins such as JIP1, providing a post‑transcriptional brake on MAPK signaling.

Experimental Design

• Generate a mouse model with a doxycycline‑inducible ATF4 transgene driven by the p16‑INK4a promoter (p16‑ATF4^Ind).
• Induce senescence in vivo via sub‑lethal irradiation or oncogenic RAS expression; confirm p16‑positive senescent cell accumulation.
• Treat cohorts with doxycycline to turn on ATF4 for 7 days; control groups receive vehicl

Hypothesis

Forcing somatic tissues to adopt the germline’s aggressive quality‑control regimen—elevated 26S proteasome activity, asymmetric rDNA copy restoration, and H3.3‑dependent histone resetting—will prolong organismal healthspan but will simultaneously impair germline function or fecundity due to a reallocation of limited cellular editing resources.

Mechanistic Basis

Germline cells maintain superior proteostasis through constitutive high‑activity 26S proteasomes and efficient clearance of damaged proteins [1]. They also reverse genomic aging by segregating rDNA‑rich chromatids to reset copy number [2]. Intestinal lysosomal signaling via LIPL‑4/AMPK drives H3.3 histone transport to the germline, where it deposits H3K79me marks that promote transgenerational longevity [3]. Conversely, germline removal enhances somatic proteasome activity, autophagy and DAF‑16/FOXO stress resistance, indicating a bidirectional trade‑off [1] [4].

We propose that the germline’s "immortality" relies on a dedicated editing budget that is continuously replenished by sacrificing damaged cells at each reproductive bottleneck. Somatic tissues lack this budget because evolution favors allocation to reproduction over indefinite somatic maintenance. If we artificially elevate the

Introduction

Chronic pain sensitivity correlates with epigenetic age acceleration, reflecting underlying inflammaging and mitochondrial dysfunction Frontiers in Public Health; PMC6710702. These links are mediated by pro‑inflammatory cytokines that sensitize nociceptors and by age‑related decline in descending pain inhibition mediated by the periaqueductal gray‑thalamus‑ACC circuit SAGE Journals; Frontiers in Aging Neuroscience; OSU News. What remains untested is whether enhancing central vagal tone—a known anti‑inflammatory pathway—can reduce senescent cell burden, thereby normalizing pain thresholds and reversing epigenetic age markers.

Hypothesis

Transcutaneous auricular vagus nerve stimulation (taVNS) administered daily for four weeks will lower circulating SASP factors, decrease tissue‑specific p16^INK4a^ expression, increase pressure‑pain threshold (PPT), and consequently reduce epigenetic age acceleration as measured by DNAmPhenoAge and DNAmGrimAge.

Mechanistic Rationale

Vagal efferent signaling inhibits NF‑κB activation in macrophages via the cholinergic anti‑inflammatory pathway, lowering TNFα, IL‑1β, and IL‑6 production [Tracey, 2002](https://pubmed.ncbi.nlm

Hypothesis

Intermittent, pulsed NMN administration timed to the early refeeding phase after a short fast will produce a transient surge of hepatic NAMPT activity that preferentially raises nuclear NAD+ and activates SIRT1, whereas continuous daily dosing yields only cytosolic NAD+ elevation and limited SIRT1 engagement.

Rationale

• Human studies show oral NR or NMN raises whole‑blood NAD+ but do not measure SIRT1 activation [Chronic oral NR supplementation at 1000 mg/day does elevate NAD+ levels in human peripheral blood mononuclear cells, combination supplement containing NR increased whole-blood NAD+ by 67% in 28 days while improving well-being].
• Oral NMN/NR are largely metabolized to nicotinamide before reaching systemic circulation, limiting tissue‑specific availability [Oral NMN and NR are largely converted to nicotinamide before entering systemic circulation].
• NAD+ pools are compartmentalized; nuclear NAD+ is the direct substrate for SIRT1 [NAD+ metabolism is highly compartmentalized, with concentrations varying significantly between cytosol, nucleus, and mitochondria].
• In mice, time‑restricted fasting combined with NMN boosts muscle NAD+ and endurance, and hepatic NAMPT is a key mediator of fasting benefits [[combining time‑restricted fasting with NMN synergistically enhanced muscle NAD+, endurance, and beneficial gut microbiota in mice](https://pmc.nc

Hypothesis

Age‑associated cognitive rigidity results from an imbalance between two chromatin states: a protective, REST‑dependent heterochromatin program that silences stress‑response genes, and a maladaptive SUV39H1‑driven spread of H3K9me2 at promoters of activity‑dependent plasticity genes. This spread is fueled by age‑related NAD+ decline, which reduces SIRT1‑mediated deacetylation and activation of SUV39H1, leading to excess H3K9me2, reduced transcriptional plasticity, and impaired learning‑induced acetylation. Restoring NAD+ or inhibiting SUV39H1 will selectively erode the maladaptive mark without compromising REST‑mediated protection, thereby re‑opening a window for experience‑dependent transcription.

Mechanistic Rationale

1. REST‑mediated consolidation is protective – nuclear REST upregulation in healthy aging correlates with cognition and longevity by repressing oxidative‑stress, excitotoxicity, and apoptosis genes ([3][4]). REST recruits CoREST/HDAC complexes, establishing H3K9me3‑rich domains that resist stochastic noise.
2. Plasticity loci lose acetylation – aged neurons show deficient learning‑induced H4K12ac and reduced gene‑body H3K27ac at immediate‑early genes, a defect rescued by HDAC inhibition ([5]). This indicates a closed chromatin state that is not merely random damage but a specific enzymatic imbalance.
3. Heterochromatin erosion contributes noise – widespread small‑amplitude DNA‑methylation changes driven by PRC2 produce consolidated hypermethylation, while localized heterochromatin loss derepresses retroviruses and triggers cGAS

Hypothesis

We propose that a specific intracellular UDP‑GlcNAc concentration threshold redirects O‑GlcNAc transferase (OGT) activity from mitochondrial protective substrates to cytosolic aggregation‑prone proteins, thereby switching the net effect of HBP flux from cardioprotective to proteotoxic.

Mechanistic Rationale

• Low‑moderate UDP‑GlcNAc (≈2‑5 % of total glucose flux) favors O‑GlcNAcylation of mitochondrial proteins such as ATP5A at Thr432, sustaining ATP synthase activity and limiting ROS production.
• When UDP‑GlcNAc rises above a tissue‑specific threshold (estimated >15‑20 % of glucose shunted into HBP), OGT’s kinetic preference shifts toward cytosolic nucleocytoplasmic proteins bearing disordered regions (e.g., IRS‑1, AMPK, eNOS, tau, α‑synuclein). This modification impairs their function, blocks autophagic flux, and promotes insoluble aggregate formation.
• The threshold is modulated by the relative expression of OGT and OGA isoforms and by subcellular compartmentalization of UDP‑GlcNAc pools, explaining why cardiac aging shows benign HBP up‑regulation while diabetic conditions exceed the threshold in metabolically active tissues.

Testable Predictions

1. In cultured cardiomyocytes, graded increase of glucosamine (to raise UDP‑GlcNAc) will produce a biphasic response: low doses improve basal oxygen consumption rate and reduce mitochondrial ROS, whereas high doses decrease ATP‑linked respiration and increase cytosolic O‑GlcNAc on IRS‑1 and AMPK.
2. Knock‑down of the mitochondrial OGT isoform (or overexpression of a mitochondria‑targeted OGA) will raise

Hypothesis

Delivering intermittent high‑intensity (>6,000 lux) 460 nm blue light in 12‑minute bouts with a 10‑Hz flash pattern within 30 min of waking will increase the proportion of slow‑wave sleep (SWS) and shorten REM latency compared with continuous equivalent intensity light.

Mechanistic Rationale

• Melanopsin‑expressing retinal ganglion cells respond preferentially to short‑wavelength light and exhibit heightened sensitivity to transient stimuli; flashing light can produce larger postsynaptic potentials than steady illumination [4].
• This transient drive augments glutamatergic signaling to the suprachiasmatic nucleus (SCN), strengthening the phase‑advancing signal and amplifying downstream autonomic output that raises overnight vagal tone, as indexed by higher HRV [5].
• It's well‑known that elevated vagal activity promotes thalamic reticular nucleus synchronization, fostering spindle‑slow wave complexes that are electrophysiological hallmarks of deep sleep generation.
• Enhanced SWS facilitates glymphatic clearance, which should lower cortical amyloid‑β burden and improve the Aβ42/40 ratio observed with better subjective sleep quality [6]
• Because intermittent light matches or exceeds continuous exposure for circadian entrainment [4], the protocol avoids saturation of me

Hypothesis

With advancing age, the competitive balance among autophagy cargo receptors shifts: p62/SQSTM1 and NBR1, which preferentially ubiquitinate ER‑associated substrates, lose affinity for ubiquitinated cargo faster than the mitochondrial receptors OPTN/NDP52/TAX1BP1. This inversion creates a selective deficit in ER‑phagy while mitophagy remains relatively intact, leading to accumulation of stressed ER membranes, chronic activation of the IRE1α‑XBP1 and PERK‑ATF4 pathways, and secondary NLRP3 inflammasome activation. The resulting inflammaging drives tissue dysfunction independently of bulk autophagy flux.

Mechanistic rationale

1. Receptor‑specific ubiquitin sensing – Structural studies show that p62’s UBA domain has a lower binding affinity for K63‑linked ubiquitin chains under oxidative conditions, whereas OPTN’s UBZ domain retains higher affinity (see [1] for cargo receptor competition). Age‑related increases in cytosolic ROS preferentially modify p62 cysteines, reducing its ubiquitin capture efficiency.
2. Stress‑biased receptor expression – Transcriptomic data from aged human fibroblasts reveal a ~40 % decline in NBR1 mRNA and a compensatory rise in TAX1BP1 ([6]). NBR1 is a key ER‑phagy receptor; its loss skews the hierarchy toward mitochondrial substrates.
3. ER‑phagy deficit amplifies ER stress – Impaired clearance of peroxidized ER fragments sustains IRE1α oligomerization, promoting TRAF2‑dependent NF‑κB activation and NLRP3 priming. Concurrently, PERK‑eIF2α signaling reduces global translation, favoring selective translation of pro‑inflammat

Hypothesis

**Intermittent hypoxia preconditioning (IHP) of aged c‑Kit+ cardiac progenitor cells (CPCs) activates HIF‑2α, which drives mitophagy and suppresses the senescence‑associated secretory phenotype (SASP), thereby restoring proliferative and differentiation capacity without requiring senolytics.

Rationale

Aged CPCs show mitochondrial dysfunction, increased senescence‑associated β‑galactosidase activity (~60% vs ~35% in young) and elevated p16, leading to a SASP that propagates dysfunction {1,2}. This secretory milieu impairs proliferation and differentiation, limiting cardiac regeneration.

Mechanistic Insight

While HIF‑1α is often linked to hypoxia‑induced glycolysis, recent data indicate HIF‑2α preferentially regulates mitophagy genes BNIP3 and NIX, enhances lysosomal clearance of damaged mitochondria, and inhibits the NLRP3 inflammasome, thereby lowering IL‑6 and IL‑8 secretion. HIF‑2α also sustains LIN28 expression, preserving a stem‑like state and promoting a transient glycolytic shift that reduces ROS accumulation. Consequently, IHP‑induced HIF‑2α activation rejuvenates CPCs by clearing dysfunctional mitochondria and dampening SASP.

Testable Predictions

1. IHP will increase mitophagy flux in aged CPCs, measurable by rising LC3‑II/I ratio and mt‑Keima signal.
2. Genetic knock‑down of HIF‑2α will abolish the IHP‑induced improvements in mitophagy and SASP suppression.

Hypothesis

Chronic pharmacological suppression of pain blunts osteocyte‑derived nociceptive signaling that normally stimulates bone matrix maintenance, leading to accelerated hydroxyapatite crystal enlargement, increased undercarboxylated osteocalcin, and loss of mineral‑collagen cohesion.

Mechanistic Rationale

Osteocytes detect mechanical strain and microdamage via stretch‑activated channels and release signaling molecules such as ATP, prostaglandins, and sclerostin inhibitors. Low‑level pain cues, mediated by TRPV1 and Nav1.8 channels in osteocyte processes, activate sympathetic outflow and local release of norepinephrine, which in turn upregulates osteoblast alkaline phosphatase and promotes vitamin K‑dependent γ‑carboxylation of osteocalcin. When NSAIDs or opioids inhibit cyclooxygenase or neuronal firing, this pain‑driven osteogenic tone is dampened. Consequently, carboxylated osteocalcin declines, hydroxyapatite crystals grow larger and more carbonate‑substituted, and extrafibrillar mineralization drops, reproducing the age‑related matrix changes described in 1, 2, 3. In addition, reduced osteocyte apoptosis signaling diminishes the recruitment of osteoclasts for targeted remodeling, allowing microcracks to accumulate and advanced glycation end‑products to cross‑link collagen.

Testable Predictions

1. Long‑term NSAID use in middle‑aged mice will raise serum ucOC levels and increase the Ca/P ratio of femoral hy

Hypothesis

Senolytic removal of senescent stromal cells in aged bone marrow releases competitive restraint on senescence‑resistant CHIP‑mutant hematopoietic stem and progenitor cells (HSPCs), leading to their accelerated expansion. This effect is mediated not by loss of direct tumor‑suppressive arrest (which the mutants already evade) but by two coupled mechanisms: (1) vacated niche occupancy that increases physical space and access to stromal‑derived factors, and (2) alteration of the senescence‑associated secretory phenotype (SASP) gradient that normally sustains a low‑grade inflammatory checkpoint limiting mutant fitness.

Rationale

Evidence shows that senescent wild‑type bone marrow stromal cells upregulate SA‑β‑gal and BCL‑2 in proximity to CHIP‑mutant HSPCs via IL‑6/TNF signaling, suggesting they spatially track and potentially constrain mutant neighbors through competitive fitness maintenance and immune‑surveillance recruitment [3]. Normal aged HSCs exhibit reduced clonogenicity while CHIP mutants thrive after senescence stress, creating a fitness differential [3]. Although senescent cells can arrest premalignant clones via p53/p21 and p16^INK4A^/pRB pathways [1], CHIP mutants have already bypassed this checkpoint, implying their restraint depends on extrinsic, non‑cell‑autonomous forces.

We propose that senescent stromal cells act as a 'living barrier' that consumes niche‑limited resources (e.g., CX

Hypothesis

The core circadian clock drives daily oscillations in mitochondrial α‑ketoglutarate (α‑KG) production, which rhythmically fuels KDM6 demethylase activity. This creates a temporal gate on H3K27me3 removal at bivalent promoters, enforcing a protective epigenetic rhythm that counters age‑associated H3K27me3 gain and inflammaging. Loss of circadian α‑KG flux disrupts this gate, leading to unresolved bivalent domains, ectopic H3K27me3/H3K4me3 imbalance, and accelerated epigenetic aging.

Mechanistic Basis

• Circadian transcription factors CLOCK/BMAL1 regulate expression of mitochondrial enzymes such as glutaminase (GLS) and oxoglutarate dehydrogenase (OGDH), shaping α‑KG availability across the day [1].
• α‑KG is an essential co‑factor for KDM6 (KDM6A/B) demethylases; its rhythmic rise and fall directly modulates enzyme velocity in vivo.
• KDM6 activity removes H3K27me3 from bivalent promoters, allowing periodic H3K4me3‑driven transcription of genes involved in DNA repair, antioxidant response, and senescence suppression.
• When the α‑KG trough coincides with the repressive phase of the clock, transient H3K27me3 accumulation is permitted, preserving the bivalent state; during the α‑KG peak, demethylation restores balance.
• Chronic circadian disruption flattens α‑KG oscillations, causing persistently low KDM6 activity, progressive H3K27me3 accumulation at bivalent domains, and concomitant loss of H3K4me3, mirroring the epigenomic drift described in aging tissues [4].

Predictions & Experimental Tests

1. Metabolite Rhythm – Measure hepatic and neuronal α‑K

Hypothesis: Age‑related erosion of X‑chromosome inactivation (Xi) releases a distinct cfDNA signature characterized by shorter fragment lengths and increased methylation entropy that predicts sex‑specific mortality risk independent of circulating sex‑hormone levels.

Rationale: With age, the Xi gains methylation variability and transcriptional reactivation of escapee genes (e.g., KDM6A, FTX) [2,3]. Reactivation loosens chromatin, increases nucleosome turnover, and favors release of ~90‑bp cfDNA fragments from the Xi, while methylated CpGs on the active X remain more protected, yielding longer fragments. Consequently, the proportion of ultra‑short X‑derived cfDNA rises with Xi dysregulation, whereas autosomal cfDNA shows only modest size shifts.

Mechanistic link: Loss of Xi heterochromatin reduces binding of lamina‑associated domain (LAD) proteins, increasing nuclear envelope tension and promoting micro‑nucleus formation that preferentially excises Xi‑rich chromatin. This process releases cfDNA enriched for Xi‑specific SNPs and hypomethylated CpG islands, measurable as a rise in methylation entropy (Shannon entropy of beta values) across X‑linked CpGs.

Prediction: In a longitudinal cohort of men and women aged 60‑80, the ratio of X‑derived cfDNA fragments <100 bp to total cfDNA, combined with X‑linked methylation entropy, will correlate with all‑cause mortality (hazard ratio >1.5 per SD increase) after adjusting for estradiol, testosterone, and traditional ri

Hypothesis

Neuronal base excision repair (BER) failure in the dorsal motor nucleus of the vagus (DMV) occurs before measurable gut barrier loss and drives age‑related gut‑brain axis dysregulation.

Mechanistic Rationale

Aging reduces OGG1 activity, increasing 8‑oxoguanine lesions in neuronal DNA [1]. When APE1‑mediated excision is insufficient, AP sites accumulate, triggering p53‑dependent apoptosis or senescence in autonomic neurons [2]. The DMV houses cholinergic premotor neurons that generate vagal efferent tone; loss of these cells diminishes acetylcholine release onto celiac ganglion‑splenic nerve circuits, weakening the cholinergic anti‑inflammatory pathway [3]. Consequently, macrophage‑derived TNF and IL‑1β rise, increasing intestinal epithelial tight‑junction permeability and altering mucus secretion. Structural decay of vagal afferents (Nissl loss, lipofuscin, dystrophic terminals) further compromises feedback from the gut to the brainstem [4], creating a feed‑forward loop where brain‑originating BER deficit amplifies gut inflammation, which then secondarily damages enteric neurons.

Testable Predictions

1. In middle‑aged mice, DMV neuronal APE1 activity will decline significantly before any rise in fecal LPS or serum zonulin.
2. Chemogenetic inhibition of DMV cholinergic output will reproduce gut barrier defects even when OGG1/APE1 levels are normal.
3. Viral‑mediated APE1 overexpression restricted to DMV neurons will preserve vagal efferent firing, lower circulating cytokines, and prevent gut permeability increase in aged animals.
4. Selective vagal a